🇺🇸 FDA
Patent

US 12264344

Protein/oligonucleotide core-shell nanoparticle therapeutics

granted A61KA61K38/44A61K38/47

Quick answer

US patent 12264344 (Protein/oligonucleotide core-shell nanoparticle therapeutics) held by Northwestern University expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/44, A61K38/47, A61K47/549, A61K47/6921